These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 16154634

  • 1. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E, Krysiak R, Wieronska JM, Smialowska M, Herman ZS.
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [Abstract] [Full Text] [Related]

  • 2. Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants.
    Obuchowicz E, Herman ZS.
    Neuropeptides; 2003 Feb; 37(1):17-24. PubMed ID: 12637031
    [Abstract] [Full Text] [Related]

  • 3. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
    Schröder U, Schröder H, Augustin W, Sabel BA.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425
    [Abstract] [Full Text] [Related]

  • 4. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R.
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [Abstract] [Full Text] [Related]

  • 5. Amphetamine-induced effects on neuropeptide Y in the rat brain.
    Obuchowicz E, Turchan J, Przewłocki R, Herman ZS.
    Pharmacol Rep; 2005 Jul; 57(3):321-9. PubMed ID: 15985714
    [Abstract] [Full Text] [Related]

  • 6. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 7. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G, Zhou LW, Morabito M, Zhang SP, Weiss B.
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [Abstract] [Full Text] [Related]

  • 8. Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum.
    Obuchowicz E, Turchan J.
    Neuropeptides; 1998 Oct; 32(5):473-80. PubMed ID: 9845010
    [Abstract] [Full Text] [Related]

  • 9. Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
    Gruber SH, Nomikos GG, Mathé AA.
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):592-600. PubMed ID: 16524702
    [Abstract] [Full Text] [Related]

  • 10. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.
    Obuchowicz E, Turchan J.
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):51-9. PubMed ID: 10082228
    [Abstract] [Full Text] [Related]

  • 11. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
    Mao L, Wang JQ.
    Synapse; 2001 Sep 01; 41(3):230-40. PubMed ID: 11418936
    [Abstract] [Full Text] [Related]

  • 12. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST, Baella SA, Stuebner NM, Crawford CA, McDougall SA.
    Brain Res; 2006 Feb 16; 1073-1074():269-75. PubMed ID: 16427034
    [Abstract] [Full Text] [Related]

  • 13. Developmental striatal critical period of activity-dependent plasticity is also a window of susceptibility for haloperidol induced adult motor alterations.
    Soiza-Reilly M, Azcurra JM.
    Neurotoxicol Teratol; 2009 Feb 16; 31(4):191-7. PubMed ID: 19336253
    [Abstract] [Full Text] [Related]

  • 14. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.
    Le Foll B, Diaz J, Sokoloff P.
    Synapse; 2003 Mar 16; 47(3):176-83. PubMed ID: 12494400
    [Abstract] [Full Text] [Related]

  • 15. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA, Mansour A, Watson SJ.
    Exp Neurol; 1994 Dec 16; 130(2):288-303. PubMed ID: 7867758
    [Abstract] [Full Text] [Related]

  • 16. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice.
    Akhisaroglu M, Kurtuncu M, Manev H, Uz T.
    Pharmacol Biochem Behav; 2005 Mar 16; 80(3):371-7. PubMed ID: 15740778
    [Abstract] [Full Text] [Related]

  • 17. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
    Harrison MB, Kumar S, Hubbard CA, Trugman JM.
    Exp Neurol; 2001 Feb 16; 167(2):321-8. PubMed ID: 11161620
    [Abstract] [Full Text] [Related]

  • 18. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors.
    Robertson GS, Lee CJ, Sridhar K, Nakabeppu Y, Cheng M, Wang YM, Caron MG.
    Eur J Neurosci; 2004 Dec 16; 20(11):3189-94. PubMed ID: 15579174
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala.
    Smiałowska M, Bajkowska M, Heilig M, Obuchowicz E, Turchan J, Maj M, Przewłocki R.
    Neuropeptides; 2001 Apr 16; 35(2):82-91. PubMed ID: 11384203
    [Abstract] [Full Text] [Related]

  • 20. Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice.
    Tammimäki A, Pietilä K, Raattamaa H, Ahtee L.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):118-25. PubMed ID: 16442094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.